The novel drug-eluting contact lens is a great substitute for traditional eye drops, which are plagued by problems, such as low drug administration efficiency, discomfort,repeated dosing. Drugs can stay on the eyeball for a sufficient period of time. Patients can have access to treatment in an appropriate state at any time. With these advantages, the novel drug-eluting contact lens is expected to become a new method for the treatment of ophthalmic diseasesfor the recovery of patients after ophthalmic surgery. It has broad application prospects in the treatment of ophthalmic diseases.

This project proposes a smart contact lens ideally capable of simultaneously observing the tear evaporation rate, the tear osmolarity,the ocular surface temperature. To solve the shortcoming of the current difficulty in quantifying DES, assist doctors in the diagnosis of dry eye conditions, the effectivenessselectivity of drugs, the treatment statusrecovery level.